Progesterone and related drugs are hormones that have various effects on the female reproductive system and body. Progesterone was first isolated from animal ovaries in 1933. It supports pregnancy by preventing menstruation and sensitizing the uterus. Synthetic progestins are used in oral contraceptives and hormone replacement therapy. Common side effects include irregular bleeding, but progestins also have therapeutic effects like preventing endometrial cancer. Progestin antagonists like mifepristone are used to terminate early pregnancy.
Convert to study guideBETA
Transform any presentation into a summarized study guide, highlighting the most important points and key insights.
8. males
Secrete 1-5
mg /day
Plasma level
0.03mcg/dl
females
During the follicular phase the level is
only slightly higherthanthat
of males
But during the luteal phase
The plasma levels range from 0.5
to 2 mcg/dl
Reaches peak in in the 3rd trimester of
pregancy
Effect=?
9. receptors
The progesterone receptor
(PR) is a progestin-
activated steroid receptor
Also known as NR3C3 ;
Nuclear receptor subfamily 3
group C member 3
It is an intranuclear
receptor
It has 2 isoforms :
PR A
PR B
PR is expressed in the
following organs:
central nervous system (CNS)
Endocrine
gastrointestinal
immune
reproductive
cardiovascular
respiratory
Uterus
ovary
cerebellum
spinal cord
hypothalamus
13. Cervix :
Progesterone causes
the production of a
viscid cervical
secretion
Vagina:
It causes leukocyte
infiltration in the
epithelium
Breast:
Progesterone cause
proliferation of the
acini in the
mammary glands
CNS:
High levels
may cause
sedation
Body tempretaure:
It causes a slight
0.5 rise in body
tempreture
Metabolism:
Impairs glucose
tolerance
They may tend to
raise LDL and lower
HDL
It stimulates
respiration
Pituitary:
They have anti
ovulatory activity by
reducing LH secretion
17. Synthetic progestin (Agonist)s
Progesterone
derivatives (21 C)
These are pure
progestins. They have
weaker anti-ovulatory
action and are used
primarily as adjutants
to estrogens for HRT,
threatened abortion
and edometriosis.
19-nortestosterone
derivatives (18 C)
They have weak estrogenic,
androgenic and anabolic
action but have potent anti-
ovulatory action. They are
mainly used in combined
contraceptive pills. Like
desogestrel and
norgestimate (prodrug)
18. Progesterone
derivatives (21 C)
Medroxyprogesterone
acetate
Megestrol acetate
Dydrogesterone
Hydroxyprogesterone
caproate
Newer compound
Nomegestrol acetate
19-nortestosterone
derivatives (18 C)
old
Norethindrone
(Norethisterone)
Lynestrenol
(Ethinylestrenol)
Allylestrenol
Levonorgestrel
(Gonane)
19-nortestosterone
derivatives (18 C)
new
(Gonanes )
Desogestrel
Norgestimate
Gestodene
19. Pharmacokinetics
Progesterone undergo high 1st pass metabolism , hence mostly given
by i.m in oily solution .
they have a short half life in the plasma , so usually prescribed for
twice or thrice-daily administration.
A micronized preparation of progesterone is rapidly absorbed after its
administrated by any route,
Absorption
21. reduction to pregnanediol, pregnanetriol and
pregnanolone.
Subsequent conjugation results in the
formation of glucuronide and sulfate
metabolites.
The metabolites of pregnanediol and
pregnanolone are excreted urine or bile
enterohepatic recycling or feces.
Metabolism
Excretion
22. Clinical uses of progestins
1.Rectify hormonal deficiency
and HRT.
2. Contraception.
3.Control of dysfunctional uterine
bleeding.
4.Treatment of dysmenorrhea.
6.Management of endometriosis.
5.Suppression of postpartum
lactation.
7.Treatment of endometrial carcinoma.
24. 1.Breast
engorgement,
headache, in body
temperature, acne,
esophageal reflux
and mood swings .
2.Irregular bleeding
or amenorrhoea .
3.The 19-
nortestosterone
derivatives plasma
HDL level .
4.In HRT may the
risk of breast cancer .
5. Diabetes may be
precipitated by long term
uses of potent agents like
levonorgestrol.
26. 19-norsteroid.
with potent competitive anti-progestational, anti-glucocorticoid,
anti-androgenic and partial agonist activity.
It is administered during different phases of ovarian cycle.
Mifepristone
Pharmacokinetics
Is orally active , bioavailability 25%
Mainly metabolized liver & excreted bile.
27. Uses
1.termination of early
pregnancy
2.As a contraceptive
given once a month
3.Cervical ripening
4.cushings syndrome
Side effects
Main side effects are
significant uterine
bleeding and possibility
of an incomplete
abortion
Also Uterine cramps
29. The birth control pill (also called "the Pill") is a
daily pill that contains hormones to change the way
the body works and prevent pregnancy. Hormones
are chemical substances that control the functioning
of the body's organs. In this case, the hormones in
the Pill control the ovaries and the uterus.
31. Combination pills
Products containing a
combination of an estrogen and
progestin are the most common
type of oral contraceptives .
The estrogens that are
commonly used in combination
pills are
Ethinyl estradiol and mestranol
The progestin in this
preparations is norethindrone
33. Progestin implants
Subdermal capsules containing
levonorgestrel offer long term
contraception
Six capsules each the size of a
matchstick are placed
subcutaneously in the upper arm
the progestin is slowly released
from the capsules
Provide contraceptive protection
for approximately five years
Totally reversible if the implants are
surgically removed
34. Mechanism
Inhibition of release of FSH and
LH
Increase viscosity of cervical
mucus
Endometrial changes
Contraction of cervix , uterus
and fallopian tube
37. Therapeutic uses
Numerous studies have shown that oral contraceptives (OC) provide
protection against a wide variety of illnesses and conditions, including
:
43. Richard AH , Pamela CC .Lippincotts illustrated reviews
.3rd edition . Donnelley W : USA ; 2006.
K.D.Tripathi.Essentials of medical pharmacology.3rd
edition.jitender p vij:new delhi;2008.
Laurance L. Brunton , john S.Lazo , Keith L.Parker .
Goodman and gilmans the pharmacologicalbasis of
theraputics.11th edition.mcGraw-hill:New york;2005.
44. List of refrences (cont.):
Bertram g. Katzung , Susan B.Masters, Anthony J.Trevor. Basic
and clinical pharmacology.12th edition. mcGraw-hill :New
york;2012.
James M. Ritter , Lionel DL , Timothy GK , Albert f . Clinical
pharmacology and therapeutics . Fifth edition . Great britain:
Hodder armond ;2008 .
Teferra A , Srinivasa A , Amare M , Solomomon W , Eshetu L
, Musie A , Dawet . Lecture notes for health science students
.ethiopia 2004
45. List of refrences (cont.):
progeterone receptors [Internet] :NURSA; 2014[cited 25 April
2015] Available from:
https://www.nursa.org/nursa/molecules/nr.jsf?doi=10.1621/9
NIE3U3DI6
progesterone[Internet] :Drugs.com;2013[cited 25 April 2015]
.Available from:
http://www.drugs.com/pro/progesterone.html
Therapeutic use of contraceptive [Internet] london:
contraceptive; 1999 [cited 2015 april 15 ].available from:
http://www.ncbi.nlm.nih.gov/pubmed/10342095
46. List of refrences (cont.):
Combined oral contraceptive pill [internet] U.S.A
:contraindications of contraceptive ; 2015 [cited 2015 april
21] . Available from:
http://en.wikipedia.org/wiki/Combined_oral_contraceptive_
pill#Development_of_an_effective_combined_oral_contrace
ptive